Online Exclusive Article

Identification and Management: Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Related to Hematopoietic Stem Cell Transplantation

Mairéad Ní Chonghaile

Karen Wolownik

sinusoidal obstruction syndrome, veno-occlusive disease, defibrotide
CJON 2018, 22(1), E7-E17. DOI: 10.1188/18.CJON.E7-E17

Background: Sinusoidal obstruction syndrome (SOS), also called hepatic veno-occlusive disease (VOD), is a potentially life-threatening complication of hematopoietic stem cell transplantation (HSCT) that affects about 1 in 7 patients undergoing this procedure. SOS/VOD is caused by the conditioning regimens administered prior to HSCT; in some cases, SOS/VOD results from chemotherapy alone. SOS/VOD usually develops within three weeks following HSCT; however, it can have later onset.

Objectives: Clearly understanding how SOS/VOD develops may support prompt detection and treatment when the condition arises.

Methods: Research on identification and management of SOS/VOD is summarized, and data from clinical trials are reviewed.

Findings: This article describes the syndrome, risk factors, signs and symptoms, and appropriate supportive care and treatment. The authors also offer some practical tips for detecting SOS/VOD and providing patient care, as well as the latest information on treating and preventing this condition.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.